Pfizer Stock Forecast

Stock Price Forecast

According to 28 analysts polled by S&P Global, Pfizer stock has a consensus rating of "Buy" and an average price target of $29.03. The average 1-year stock price forecast is 3.68% higher than the current stock price, while the lowest is $25 (-10.71%) and the highest is $35.75 (+27.68%).

Price Target: $29.03 (+3.68%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$25	$29.03	$28	$35.75
Change	-10.71%	+3.68%	0.00%	+27.68%

Analyst Ratings

The average analyst rating for Pfizer stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	9	9	8	8	8	8
Buy	2	2	2	2	2	2
Hold	15	16	16	16	16	16
Sell	2	1	1	1	1	1
Strong Sell	1	1	1	1	1	1
Total	29	29	28	28	28	28

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luisa Hector Berenberg Bank	Berenberg Bank	Hold Maintains $25	Hold	Maintains	$25	-10.71%	Oct 7, 2026
Terence Flynn Morgan Stanley	Morgan Stanley	Hold Reiterates $28	Hold	Reiterates	$28	n/a	Oct 7, 2026
Louise Chen Scotiabank	Scotiabank	Buy Maintains $30 → $33	Buy	Maintains	$30 → $33	+17.86%	Oct 6, 2026
Unknown Analyst Leerink Partners No rating	Leerink Partners	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Oct 3, 2026
Akash Tewari Jefferies	Jefferies	Buy Reiterates $35	Buy	Reiterates	$35	+25.00%	Oct 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

62.28B

from 62.58B

-0.47%

from 62.58B

Revenue Next Year

59.91B

from 62.28B

-3.80%

from 62.28B

EPS This Year

2.98

from 3.22

-7.60%

from 3.22

EPS Next Year

2.90

from 2.98

-2.64%

from 2.98

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	81.29B	101.18B	59.55B	63.63B	62.58B	62.28B
Revenue Growth	95.17%	24.47%	-41.14%	6.84%	-1.65%	-0.47%
Gross Profit	50.60B	67.08B	35.57B	46.44B	47.44B	46.76B
Gross Margin	62.25%	66.30%	59.72%	72.98%	75.81%	75.07%
Operating Income	26.98B	39.84B	6.32B	15.56B	19.16B	21.38B
Net Income	21.98B	31.37B	2.12B	8.03B	7.77B	8.90B
EPS	-	-	-	-	3.22	2.98
EPS Growth	-	-	-	-	3.54%	-7.60%
Forward PE	10.64	10.82	19.25	9.91	8.54	9.41
Dividend / Share	1.56	1.60	1.64	1.68	1.72	1.72
Dividend Growth	2.63%	2.56%	2.50%	2.44%	2.38%	0.08%
Free Cash Flow	-	-	-	-	9.08B	18.87B
No. Analysts	-	-	-	-	-	25

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	63.9B
Avg	62.3B
Low	61.2B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	2.1%
Avg	-0.5%
Low	-2.3%

EPS Forecast

Chart

EPS	2026	2027	2028
High	3.10
Avg	2.98
Low	2.88

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-3.7%
Avg	-7.6%
Low	-10.6%